Synthetic Strength: Positioning Biomanufacturing as a U.S. Strategic Asset
Échec de l'ajout au panier.
Échec de l'ajout à la liste d'envies.
Échec de la suppression de la liste d’envies.
Échec du suivi du balado
Ne plus suivre le balado a échoué
Synthetic Strength: Positioning Biomanufacturing as a U.S. Strategic Asset
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
Join guest host Dr. Liz Specht for a conversation with Matt Spence, the managing director and global head of venture capital banking at Barclays. In this episode Dr. Spence discusses the role food security plays in national security and how the government can incentivize and support biotechnology research and development. The episode explores how synthetic biology can be leveraged into additional defense uses and dispels common misconceptions about synthetic biology and national security.
To receive updates about the conference please join our mailing list here: https://www.emergingtechnologiesinstitute.org/sign-uphttp://emergingtechnologiesinstitute.orghttps://www.facebook.com/EmergingTechETIhttps://www.linkedin.com/company/ndia-eti-emerging-technologies-institutehttps://www.twitter.com/EmergingTechETI